HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

197.500

+14.2007.75%

Volume:1.73M

Turnover:337.52M

Market Cap:17.94B

PE:-4.24

High:200.200

Open:183.700

Low:183.700

Close:183.300

52wk High:451.200

52wk Low:158.500

Shares:90.83M

HK Float Shares:90.83M

Volume Ratio:1.99

T/O Rate:1.91%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-46.603

ROE:-65.93%

ROA:-24.28%

PB:10.56

PE(LYR):-4.24

PS:18.19

Loading ...

Overview Company News Filings

Stock Track | Duality Biotherapeutics Soars 5% Intraday as Analysts Boost Estimates After Earnings Report

Earnings Update: Duality Biotherapeutics, Inc. (HKG:9606) Just Reported And Analysts Are Boosting Their Estimates

Simply Wall St.

HK Pharma Stocks Gained. XuanzhuBio Up 9%; Xtalpi, Lepu Bio And Ascletis Up 6%; Akeso Up 5%; Skb Bio Up 4%.

Tiger Newspress

Dualitybio (9606.HK) Announces 2025 Annual Results

THOMSON REUTERS

Press Release: DualityBio (9606.HK) Announces 2025 Annual Results

Stock Track | Duality Biotherapeutics Plummets 5.04% Intraday on Widened 2025 Loss and Revenue Decline

HK Pharma Stocks Gained. Wuxi XDC Up 8%; Wuxi AppTec Up 7%; Transthera And HBM Up 5%; Keymed Bio And Innocare Up 4%; Wuxi Bio And Remegen Up 3%

Tiger Newspress

BRIEF-Duality Biotherapeutics FY Revenue Rmb1.85 Billion

BRIEF-Duality Biotherapeutics Inc Says Si Wen Tendered Resignation As Exec Director

DUALITYBIO-B Reports 2025 Revenue of Approximately 18.52 Billion Yuan, Marking Significant Pipeline and Operational Progress

DualityBio Posts Wider 2025 Loss on Fair-Value Impact; Core ADC Programs Advance Toward Commercial Stage

Bulletin Express

DUALITYBIO-B (09606) Announces Dr. Hua Haiqing Appointed as Executive Director

Duality Biotherapeutics FY2025 loss attributable to owners widened 146.99% to RMB 2,594,827,000

Duality Biotherapeutics reports DB-1303 Phase 3 trial meets primary PFS endpoint

Duality Biotherapeutics - Loss for Year Attributable RMB2.59 Bln

THOMSON REUTERS

Duality Biotherapeutics Inc - Si Wen Tendered Resignation as Executive Director

THOMSON REUTERS

Duality Biotherapeutics appoints HUA Haiqing as executive director and names ZHANG Shaoren CFO

Duality Biotherapeutics Inc - Zhang Shaoren Has Been Appointed as CFO

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/09606/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":197.5,"timestamp":1789718912007,"preClose":183.3,"halted":0,"volume":1731467,"delay":0,"changeRate":0.07746863066011996,"floatShares":90833600,"shares":90833600,"eps":-46.60272227321581,"marketStatus":"Market Closed","change":14.2,"latestTime":"09-18 16:08:32","open":183.7,"high":200.2,"low":183.7,"amount":337516438,"amplitude":0.090016,"askPrice":197.5,"askSize":4800,"bidPrice":195.8,"bidSize":16800,"shortable":3,"etf":0,"ttmEps":-18.868410665552656,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789954200000},"marketStatusCode":7,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":183.3,"openAndCloseTimeList":[[1789695000000,1789704000000],[1789707600000,1789718400000]],"volumeRatio":1.991515510767703,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":90833600,"roa":"-24.28%","roe":"-65.93%","lyrEps":-46.602722,"volumeRatio":1.991515510767703,"shares":90833600,"dividePrice":0,"high":200.2,"amplitude":0.090016,"preClose":183.3,"low":183.7,"week52Low":158.5,"pbRate":"10.56","psRate":"18.19","week52High":451.2,"institutionHeld":0,"latestPrice":197.5,"committee":0.555556,"eps":-46.60272227321581,"divideRate":0,"volume":1731467,"delay":0,"ttmEps":-18.868410665552656,"open":183.7,"prevYearClose":298.2,"prevWeekClose":168.7,"prevMonthClose":184.3,"prevQuarterClose":181.2,"fiveDayClose":168.7,"twentyDayClose":194.5,"sixtyDayClose":168.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-23","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2026-09-17","current":-10.46723,"percent":0.361823,"low":-29.984477,"twenty":-16.019043,"median":-9.342917,"eighty":-6.847901,"high":-4.703556,"avg":-11.518791,"sd":6.115194,"marketCap":16580000806},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-17","current":-9.52866,"twenty":-25.090759,"median":-16.467132,"eighty":-11.127698,"marketCap":29421719428},{"date":"2025-10-24","current":-8.24833,"twenty":-24.683236,"median":-16.401371,"eighty":-10.383008,"marketCap":25477694801},{"date":"2025-10-31","current":-8.936138,"twenty":-24.228898,"median":-16.208434,"eighty":-10.01166,"marketCap":27643386896},{"date":"2025-11-07","current":-8.115895,"twenty":-24.0933,"median":-15.983588,"eighty":-9.661913,"marketCap":25090335240},{"date":"2025-11-14","current":-9.615008,"twenty":-24.036348,"median":-15.846935,"eighty":-9.533336,"marketCap":29809078990},{"date":"2025-11-21","current":-8.88084,"twenty":-23.659864,"median":-15.493415,"eighty":-9.411746,"marketCap":27520136126},{"date":"2025-11-28","current":-9.805814,"twenty":-23.032171,"median":-15.270261,"eighty":-9.358381,"marketCap":30496838785},{"date":"2025-12-05","current":-9.522579,"twenty":-22.810207,"median":-15.147164,"eighty":-9.358381,"marketCap":29666872704},{"date":"2025-12-12","current":-9.227769,"twenty":-22.078047,"median":-15.043786,"eighty":-9.232281,"marketCap":28801588916},{"date":"2025-12-19","current":-9.562517,"twenty":-22.024358,"median":-14.816055,"eighty":-9.195431,"marketCap":29916743432},{"date":"2025-12-24","current":-8.86445,"twenty":-21.960012,"median":-14.582474,"eighty":-9.185632,"marketCap":27819193982},{"date":"2026-01-02","current":-8.361415,"twenty":-21.780535,"median":-14.405796,"eighty":-9.071858,"marketCap":26343799029},{"date":"2026-01-09","current":-10.158481,"twenty":-21.573184,"median":-14.143758,"eighty":-9.138635,"marketCap":32085396254},{"date":"2026-01-16","current":-10.130227,"twenty":-21.338723,"median":-13.671075,"eighty":-9.159542,"marketCap":32100133626},{"date":"2026-01-23","current":-9.450777,"twenty":-21.128733,"median":-12.833558,"eighty":-9.159542,"marketCap":29918397524},{"date":"2026-01-30","current":-9.27281,"twenty":-20.989151,"median":-11.556174,"eighty":-9.159542,"marketCap":29489203537},{"date":"2026-02-06","current":-8.834279,"twenty":-20.864442,"median":-11.154997,"eighty":-9.026205,"marketCap":28165855410},{"date":"2026-02-13","current":-9.445101,"twenty":-20.730279,"median":-10.443288,"eighty":-9.076015,"marketCap":30286271904},{"date":"2026-02-20","current":-9.824687,"twenty":-20.674464,"median":-10.43817,"eighty":-9.09489,"marketCap":31458062186},{"date":"2026-02-27","current":-8.771359,"twenty":-20.006759,"median":-10.305855,"eighty":-9.047703,"marketCap":28393379910},{"date":"2026-03-06","current":-8.859488,"twenty":-19.896232,"median":-10.18539,"eighty":-8.969972,"marketCap":28447462538},{"date":"2026-03-13","current":-7.555838,"twenty":-19.630572,"median":-10.144354,"eighty":-8.935093,"marketCap":24373237865},{"date":"2026-03-20","current":-7.859442,"twenty":-19.432697,"median":-9.991099,"eighty":-8.867218,"marketCap":25256587462},{"date":"2026-03-27","current":-8.718949,"twenty":-19.118727,"median":-9.951719,"eighty":-8.854358,"marketCap":25617138318},{"date":"2026-04-02","current":-9.880216,"twenty":-19.012497,"median":-9.885599,"eighty":-8.850342,"marketCap":29168564250},{"date":"2026-04-10","current":-9.180446,"twenty":-18.964111,"median":-9.878849,"eighty":-8.85641,"marketCap":27311727342},{"date":"2026-04-17","current":-9.417233,"twenty":-18.904163,"median":-9.820225,"eighty":-8.842311,"marketCap":28027927148},{"date":"2026-04-24","current":-8.878352,"twenty":-18.860571,"median":-9.805814,"eighty":-8.846908,"marketCap":26425587896},{"date":"2026-04-30","current":-8.372511,"twenty":-18.781003,"median":-9.783435,"eighty":-8.82699,"marketCap":24926391864},{"date":"2026-05-08","current":-7.738947,"twenty":-18.469318,"median":-9.736996,"eighty":-8.785939,"marketCap":23120131584},{"date":"2026-05-15","current":-6.609967,"twenty":-18.384608,"median":-9.691452,"eighty":-8.751075,"marketCap":20699742808},{"date":"2026-05-22","current":-6.440114,"twenty":-18.185423,"median":-9.652725,"eighty":-8.708072,"marketCap":20121739519},{"date":"2026-05-29","current":-6.506712,"twenty":-18.096065,"median":-9.620334,"eighty":-8.669056,"marketCap":20400514838},{"date":"2026-06-05","current":-5.374082,"twenty":-18.0452,"median":-9.575685,"eighty":-8.511806,"marketCap":16873830092},{"date":"2026-06-12","current":-5.36331,"twenty":-17.183112,"median":-9.557279,"eighty":-8.481744,"marketCap":16828616185},{"date":"2026-06-18","current":-5.321722,"twenty":-16.860136,"median":-9.537613,"eighty":-8.412993,"marketCap":16738188371},{"date":"2026-06-26","current":-4.703556,"twenty":-16.761475,"median":-9.522579,"eighty":-8.375473,"marketCap":14721648119},{"date":"2026-07-03","current":-6.212828,"twenty":-16.718804,"median":-9.508222,"eighty":-8.310046,"marketCap":19460065572},{"date":"2026-07-10","current":-6.457487,"twenty":-16.608112,"median":-9.462457,"eighty":-8.218812,"marketCap":20201573647},{"date":"2026-07-17","current":-6.192643,"twenty":-16.533051,"median":-9.445101,"eighty":-8.097368,"marketCap":19441980010},{"date":"2026-07-24","current":-6.744145,"twenty":-16.505793,"median":-9.428231,"eighty":-7.995787,"marketCap":21178194038},{"date":"2026-07-31","current":-5.225281,"twenty":-16.472851,"median":-9.409879,"eighty":-7.856069,"marketCap":16439776585},{"date":"2026-08-07","current":-5.555188,"twenty":-16.434203,"median":-9.398864,"eighty":-7.73561,"marketCap":17511664790},{"date":"2026-08-14","current":-5.519506,"twenty":-16.417169,"median":-9.342917,"eighty":-7.473767,"marketCap":17421211976},{"date":"2026-08-21","current":-5.561665,"twenty":-16.354018,"median":-9.310353,"eighty":-6.918832,"marketCap":17593072323},{"date":"2026-08-28","current":-5.723357,"twenty":-16.253166,"median":-9.270261,"eighty":-6.767757,"marketCap":18108653362},{"date":"2026-09-04","current":-9.738306,"twenty":-16.191745,"median":-9.310353,"eighty":-6.781144,"marketCap":16344823489},{"date":"2026-09-11","current":-9.079348,"twenty":-16.117099,"median":-9.324437,"eighty":-6.805148,"marketCap":15259389721},{"date":"2026-09-17","current":-9.85224,"twenty":-16.019043,"median":-9.342917,"eighty":-6.847901,"marketCap":16580000806}],"updateTime":1789773750505},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1178986582","title":"Stock Track | Duality Biotherapeutics Soars 5% Intraday as Analysts Boost Estimates After Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1178986582","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178986582?lang=en_us&edition=fundamental","pubTime":"2026-03-27 10:17","pubTimestamp":1774577840,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics (HKG:09606) saw its stock price soar 5.00% during intraday trading on Friday, following the release of its annual results and subsequent analyst updates.The biotech company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622135258","title":"Earnings Update: Duality Biotherapeutics, Inc. (HKG:9606) Just Reported And Analysts Are Boosting Their Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622135258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622135258?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:05","pubTimestamp":1774562708,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. ( HKG:9606 ) shareholders are probably feeling a little disappointed, since its shares...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/earnings-update-duality-biotherapeutics-inc-hkg9606-just-rep","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/earnings-update-duality-biotherapeutics-inc-hkg9606-just-rep","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148472362","title":"HK Pharma Stocks Gained. XuanzhuBio Up 9%; Xtalpi, Lepu Bio And Ascletis Up 6%; Akeso Up 5%; Skb Bio Up 4%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1148472362","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148472362?lang=en_us&edition=fundamental","pubTime":"2026-03-26 09:54","pubTimestamp":1774490045,"startTime":"0","endTime":"0","summary":"HK Pharma Stocks Gained. XuanzhuBio up 9%; Xtalpi, Lepu Bio and Ascletis up 6%; Akeso up 5%; Skb Bio up 4%. ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","02228","06606","02137","02359","03347","09606","09995","03759","06978","02575","09688","09966","02269","01672","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621548880","title":"Dualitybio (9606.HK) Announces 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2621548880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621548880?lang=en_us&edition=fundamental","pubTime":"2026-03-24 15:43","pubTimestamp":1774338231,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA5JTWZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","HK0000500386.USD","HK0000252152.HKD","09606","LU2543165471.USD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621054815","title":"Press Release: DualityBio (9606.HK) Announces 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2621054815","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621054815?lang=en_us&edition=fundamental","pubTime":"2026-03-24 15:43","pubTimestamp":1774338180,"startTime":"0","endTime":"0","summary":"HONG KONG, March 24, 2026 /PRNewswire/ -- Duality Biotherapeutics, Inc. , a leading global clinical-stage innovative biopharmaceutical company, today announced its first annual results since listing on April 15, 2025 , providing a comprehensive update on its global clinical pipeline and corporate operations.During the reporting period, the Company achieved total revenue of RMB1.852 billion , providing a solid financial foundation for the continuous advancement of business. R&D investment remained at a high level, with annual R&D expenses reaching RMB838 million; the adjusted loss for the year was RMB389 million . The Company maintained a healthy cash flow position, with cash and bank balances of RMB3.325 billion as of the end o","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4118","HK0000252152.HKD","BK4585","BK4566","09606","LU2543165471.USD","BK4588","HK0000252160.HKD","HK0000500386.USD","DB","BK4552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148394372","title":"Stock Track | Duality Biotherapeutics Plummets 5.04% Intraday on Widened 2025 Loss and Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1148394372","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148394372?lang=en_us&edition=fundamental","pubTime":"2026-03-24 11:09","pubTimestamp":1774321752,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics (09606.HK) shares plummeted 5.04% during intraday trading on Tuesday, following the release of its full-year 2025 financial results.The biopharmaceutical company reported a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156264604","title":"HK Pharma Stocks Gained. Wuxi XDC Up 8%; Wuxi AppTec Up 7%; Transthera And HBM Up 5%; Keymed Bio And Innocare Up 4%; Wuxi Bio And Remegen Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156264604","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156264604?lang=en_us&edition=fundamental","pubTime":"2026-03-24 09:46","pubTimestamp":1774316807,"startTime":"0","endTime":"0","summary":"HK Pharma Stocks Gained. Wuxi XDC up 8%; Wuxi AppTec up 7%; Transthera and HBM up 5%; Keymed Bio and Innocare up 4%; Wuxi Bio and Remegen up 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","06606","06978","02268","01672","09688","02359","03759","02162","09966","02137","09606","09995","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621707467","title":"BRIEF-Duality Biotherapeutics FY Revenue Rmb1.85 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2621707467","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621707467?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:31","pubTimestamp":1774279896,"startTime":"0","endTime":"0","summary":"BRIEF-Duality Biotherapeutics FY Revenue Rmb1.85 BillionMarch 23 (Reuters) - Duality Biotherapeutics Inc 9606.HK:FY  REVENUE RMB1.85 BILLIONLOSS FOR YEAR ATTRIBUTABLE RMB2.59 BILLIONFurther company coverage: 9606.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B09R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","LU2543165471.USD","09606","HK0000252160.HKD","HK0000500386.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621570110","title":"BRIEF-Duality Biotherapeutics Inc Says Si Wen Tendered Resignation As Exec Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2621570110","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621570110?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:01","pubTimestamp":1774274511,"startTime":"0","endTime":"0","summary":"BRIEF-Duality Biotherapeutics Inc Says Si Wen Tendered Resignation As Exec DirectorMarch 23  - Duality Biotherapeutics 9606.HK:SI WEN TENDERED HER RESIGNATION AS AN EXECUTIVE DIRECTORHUA HAIQING HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTORZHANG SHAOREN HAS BEEN APPOINTED AS CFOFurther company coverage: 9606.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0S6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","BK1161","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141225275","title":"DUALITYBIO-B Reports 2025 Revenue of Approximately 18.52 Billion Yuan, Marking Significant Pipeline and Operational Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1141225275","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141225275?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:58","pubTimestamp":1774270703,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) announced its 2025 financial results, achieving revenue of approximately 18.52 billion yuan and a gross profit of about 5.89 billion yuan. Research and development expenses were...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","HK0000500386.USD","BK1161","LU2543165471.USD","HK0000252160.HKD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113759417","title":"DualityBio Posts Wider 2025 Loss on Fair-Value Impact; Core ADC Programs Advance Toward Commercial Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=1113759417","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113759417?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:41","pubTimestamp":1774269709,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics (DualityBio, 09606) reported audited results for the year to 31 December 2025: Financial performance   • Revenue slipped 4.60 % to RMB 1.85 billion, reflecting lower milestone...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108032269","title":"DUALITYBIO-B (09606) Announces Dr. Hua Haiqing Appointed as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1108032269","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108032269?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:38","pubTimestamp":1774269511,"startTime":"0","endTime":"0","summary":"Effective March 23, 2026: (1) Ms. Si Wen has resigned from her positions as an executive director and a member of the remuneration committee; (2) Dr. Hua Haiqing has been appointed as an executive...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000252160.HKD","09606","HK0000500386.USD","LU2543165471.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621705941","title":"Duality Biotherapeutics FY2025 loss attributable to owners widened 146.99% to RMB 2,594,827,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2621705941","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621705941?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:38","pubTimestamp":1774269495,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics published an annual results announcement reporting FY 2025 revenue of RMB 1.9 billion, down 4.61%.FY 2025 loss for the year was RMB 2.6 billion and adjusted loss for the year was RMB 388.8 million, more than doubled.FY 2025 R&D expenses were RMB 837.8 million, up 0.12%.Cash and bank balances were RMB 3.3 billion as of Dec. 31, 2025, up 131.55%.Pipeline updates included a Phase 3 China trial of trastuzumab pamirtecan  meeting its primary endpoint of PFS versus T-DM1, and DB-1310 receiving two FDA Fast Track designations in 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operate","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDLbdzsV0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000252160.HKD","BK1161","LU2543165471.USD","HK0000500386.USD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621070594","title":"Duality Biotherapeutics reports DB-1303 Phase 3 trial meets primary PFS endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2621070594","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621070594?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:38","pubTimestamp":1774269487,"startTime":"0","endTime":"0","summary":"Duality reported progress across its antibody-drug conjugate portfolio, including 10 clinical-stage programs that have enrolled more than 3,200 patients globally.In breast cancer, the company said DB-1303 met a primary endpoint in a Phase 3 study versus T-DM1, supporting a potential path toward expanded use in later-line HER2+ disease.For prostate cancer, updated DB-1311 data in 146 heavily pretreated mCRPC patients showed a median rPFS of 11.3 months and a median OS of 22.5 months, positioning the asset for a planned global Phase 3 trial starting in 2026.In lung and breast cancer settings, Duality said DB-1310 received two FDA fast track designations, which could shorten development timelines and broaden partnering options.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL3RdLMn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","09606","HK0000500386.USD","BK1161","HK0000252160.HKD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621954705","title":"Duality Biotherapeutics - Loss for Year Attributable RMB2.59 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2621954705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621954705?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:37","pubTimestamp":1774269478,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B09R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000500386.USD","HK0000252152.HKD","BK1161","09606","LU2543165471.USD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621063703","title":"Duality Biotherapeutics Inc -  Si Wen Tendered Resignation as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2621063703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621063703?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:25","pubTimestamp":1774268729,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0S7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD","BK1161","09606","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621703004","title":"Duality Biotherapeutics appoints HUA Haiqing as executive director and names ZHANG Shaoren CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2621703004","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621703004?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:25","pubTimestamp":1774268718,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics said executive director Wen Si resigned from the board and the remuneration committee for personal career development reasons, and will continue as executive director of human resources.Haiqing Hua was appointed an executive director after serving at the company as senior vice president and head of drug discovery, having joined in July 2021 as vice president and head of drug discovery.Hua previously held drug discovery and development roles including principal scientist at Lilly China R&D and work at Shanghai Hansoh BioMedical.Shaoren Zhang was appointed chief financial officer and is currently an executive director and vice president of finance, responsible for the group’s financial strategy, corporate finance, and capital management.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL1R9wLD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000252152.HKD","09606","BK1161","LU2543165471.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621703066","title":"Duality Biotherapeutics Inc -  Zhang Shaoren Has Been Appointed as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2621703066","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621703066?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:25","pubTimestamp":1774268712,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0S6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2543165471.USD","09606","BK1161","HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":8,"totalSize":158,"code":"91000000","status":"200"}]}}